Allstate Corp Has $1.54 Million Stock Position in Ventas, Inc. $VTR

Allstate Corp boosted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 387.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,044 shares of the real estate investment trust’s stock after purchasing an additional 17,518 shares during the period. Allstate Corp’s holdings in Ventas were worth $1,543,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Ventas by 4.1% in the second quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock valued at $4,533,937,000 after buying an additional 2,854,751 shares during the period. State Street Corp raised its holdings in shares of Ventas by 5.2% in the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock valued at $1,781,267,000 after purchasing an additional 1,388,678 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Ventas by 4.9% in the second quarter. Geode Capital Management LLC now owns 12,226,283 shares of the real estate investment trust’s stock valued at $769,061,000 after acquiring an additional 574,663 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Ventas by 6.3% in the second quarter. Charles Schwab Investment Management Inc. now owns 5,597,778 shares of the real estate investment trust’s stock valued at $353,500,000 after buying an additional 331,477 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in Ventas by 1.0% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 5,570,471 shares of the real estate investment trust’s stock valued at $351,775,000 after purchasing an additional 53,614 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Peter J. Bulgarelli sold 2,229 shares of Ventas stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $80.08, for a total value of $178,498.32. Following the completion of the transaction, the chief executive officer directly owned 106,488 shares in the company, valued at approximately $8,527,559.04. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the sale, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This trade represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 494,005 shares of company stock worth $37,132,767 over the last 90 days. Corporate insiders own 1.00% of the company’s stock.

Ventas Price Performance

NYSE VTR opened at $78.18 on Wednesday. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. The company has a market cap of $36.72 billion, a PE ratio of 150.35, a price-to-earnings-growth ratio of 1.94 and a beta of 0.78. Ventas, Inc. has a 52 week low of $58.22 and a 52 week high of $81.89. The firm’s 50-day simple moving average is $78.53 and its two-hundred day simple moving average is $72.12.

Ventas (NYSE:VTR) last posted its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.01. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter last year, the company earned $0.80 earnings per share. The company’s revenue was up 20.5% on a year-over-year basis. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Research analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were issued a dividend of $0.48 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This represents a $1.92 dividend on an annualized basis and a yield of 2.5%. Ventas’s payout ratio is presently 369.23%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on VTR shares. The Goldman Sachs Group initiated coverage on shares of Ventas in a report on Friday, January 9th. They issued a “buy” rating and a $94.00 price target on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Scotiabank upped their price target on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a research report on Thursday, November 13th. Finally, KeyCorp lifted their price objective on Ventas from $70.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $81.63.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.